{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:41Z","timestamp":1786981481585,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["Grant 16DZ0500401"],"award-info":[{"award-number":["Grant 16DZ0500401"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11046-018-0305-2","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T03:02:47Z","timestamp":1554778967000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China"],"prefix":"10.1007","volume":"184","author":[{"given":"Liang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmojtaba","family":"Seyedmousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-na","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palida","family":"Abulize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-qing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-3868","authenticated-orcid":false,"given":"Shu-wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/pgmj.55.647.645","volume":"55","author":"R Hurley","year":"1979","unstructured":"Hurley R, de Louvois J. Candida vaginitis. Postgrad Med J. 1979;55:645.","journal-title":"Postgrad Med J"},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/CMR.00076-09","volume":"23","author":"JM Achkar","year":"2010","unstructured":"Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23:253\u201373.","journal-title":"Clin Microbiol Rev"},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","volume":"369","author":"JD Sobel","year":"2007","unstructured":"Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961\u201371.","journal-title":"Lancet"},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/mmy\/myv082","volume":"54","author":"C Ying","year":"2016","unstructured":"Ying C, Zhang H, Tang Z, Chen H, Gao J, Yue C. Antifungal susceptibility and molecular typing of 115 Candida albicans isolates obtained from vulvovaginal candidiasis patients in 3 Shanghai maternity hospitals. Med Mycol. 2016;54:394\u20139.","journal-title":"Med Mycol"},{"key":"305_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11046-014-9780-2","volume":"178","author":"S Gamarra","year":"2014","unstructured":"Gamarra S, Morano S, Dudiuk C, Mancilla E, Nardin ME, de los Angeles M\u00e9ndez E, et al. Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital. Mycopathologia. 2014;178:251\u20138.","journal-title":"Mycopathologia"},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jiac.2015.08.008","volume":"22","author":"M Nagashima","year":"2016","unstructured":"Nagashima M, Yamagishi Y, Mikamo H. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. J Infect Chemother. 2016;22:124\u20136.","journal-title":"J Infect Chemother"},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/01443615.2013.834306","volume":"33","author":"A G\u00fczel","year":"2013","unstructured":"G\u00fczel A, K\u00fc\u00e7\u00fckg\u00f6z-G\u00fcle\u00e7 \u00dc, Aydin M, G\u00fcmral R, Kalkanci A, Ilkit M. Candida vaginitis during contraceptive use: the influence of methods, antifungal susceptibility and virulence patterns. J Obstet Gynaecol. 2013;33:850\u20136.","journal-title":"J Obstet Gynaecol"},{"key":"305_CR8","first-page":"51","volume":"25","author":"RF P\u00e1dua De","year":"2003","unstructured":"De P\u00e1dua RF, Guilhermetti E, Svidzinski TE. In vitro activity of antifungal agents on yeasts isolated from vaginal secretion. Acta Scientiarum. 2003;25:51\u20134.","journal-title":"Acta Scientiarum."},{"key":"305_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/01443615.2013.767323","volume":"33","author":"A Kalkanci","year":"2013","unstructured":"Kalkanci A, G\u00fczel A, Jabban I, Aydin M, Ilkit M, Ku\u015ftimur S. Candida vaginitis in non-pregnant patients: a study of antifungal susceptibility testing and virulence factors. J Obstet Gynaecol. 2013;33:378\u201383.","journal-title":"J Obstet Gynaecol"},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/13693786.2012.662597","volume":"50","author":"A Kalkanci","year":"2012","unstructured":"Kalkanci A, G\u00fczel AB, Khalil IIJ, Aydin M, Ilkit M, Ku\u015ftimur S. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Med Mycol. 2012;50:585\u201393.","journal-title":"Med Mycol"},{"key":"305_CR11","first-page":"145","volume":"48","author":"TM Brandolt","year":"2017","unstructured":"Brandolt TM, Klafke GB, Gon\u00e7alves CV, Bitencourt LR, Martinez AMBd, Mendes JF, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz. J Microbiol. 2017;48:145\u201350.","journal-title":"J Microbiol."},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/JCM.43.5.2155-2162.2005","volume":"43","author":"SS Richter","year":"2005","unstructured":"Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43:2155\u201362.","journal-title":"J Clin Microbiol."},{"key":"305_CR13","doi-asserted-by":"crossref","first-page":"201953","DOI":"10.1093\/ecam\/neq029","volume":"2011","author":"KFD Dota","year":"2011","unstructured":"Dota KFD, Consolaro MEL, Svidzinski TIE, Bruschi ML. Antifungal activity of Brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. Evid-Based Complement Altern. 2011;2011:201953.","journal-title":"Evid-Based Complement Altern"},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1128\/AAC.00118-10","volume":"54","author":"SH Ge","year":"2010","unstructured":"Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China. Antimicrob Agents Chemother. 2010;54:3126\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"305_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/myc.12204","volume":"57","author":"JY Zhang","year":"2014","unstructured":"Zhang JY, Liu JH, Liu FD, Xia YH, Wang J, Liu X, et al. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses. 2014;57:584\u201391.","journal-title":"Mycoses"},{"key":"305_CR16","first-page":"199","volume":"32","author":"S Asticcioli","year":"2009","unstructured":"Asticcioli S, Sacco L, Daturi R, Matti C, Nucleo E, Zara F, et al. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007. New Microbiol. 2009;32:199\u2013204.","journal-title":"New Microbiol"},{"key":"305_CR17","first-page":"1300","volume":"42","author":"LB Dias","year":"2011","unstructured":"Dias LB. Melhem MdSC, Szeszs MW, Meirelles Filho J, Hahn RC. Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests. Braz. J Microbiol. 2011;42:1300\u20137.","journal-title":"J Microbiol."},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0463.2006.apm_360.x","volume":"114","author":"SK Ozcan","year":"2006","unstructured":"Ozcan SK, Budak F, Yucesoy G, Susever S, Willke A. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women. APMIS. 2006;114:139\u201345.","journal-title":"APMIS."},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1447-0756.2008.00817.x","volume":"34","author":"SR Fan","year":"2008","unstructured":"Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J Obstet Gynaecol Res. 2008;34:561\u20136.","journal-title":"J Obstet Gynaecol Res."},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mycmed.2014.01.060","volume":"24","author":"X Liu","year":"2014","unstructured":"Liu X, Fan S, Peng Y, Zhang H. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. J Mycol Med. 2014;24:106\u201311.","journal-title":"J Mycol Med."},{"key":"305_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.4103\/0366-6999.181964","volume":"129","author":"FJ Wang","year":"2016","unstructured":"Wang FJ, Zhang D, Liu ZH, Wu WX, Bai HH, Dong HY. Species distribution and in vitro antifungal susceptibility of vulvovaginal Candida isolates in China. Chin Med J Peking. 2016;129:1161\u20135.","journal-title":"Chin Med J Peking."},{"key":"305_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1099\/jmm.0.000024","volume":"64","author":"XY Shi","year":"2015","unstructured":"Shi XY, Yang YP, Zhang Y, Li W, Wang JD, Huang WM. Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China. J Med Microbiol. 2015;64:390\u20133.","journal-title":"J Med Microbiol"},{"issue":"50","key":"305_CR23","first-page":"2846","volume":"2012","author":"MA Pfaller","year":"2010","unstructured":"Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods 2010 to 2012. J Clin Microbiol. 2010;2012(50):2846\u201356.","journal-title":"J Clin Microbiol"},{"key":"305_CR24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1128\/JCM.35.5.1216-1223.1997","volume":"35","author":"C Kurtzman","year":"1997","unstructured":"Kurtzman C, Robnett C. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5\u2032end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol. 1997;35:1216\u201323.","journal-title":"J Clin Microbiol"},{"key":"305_CR25","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 3rd edition; Document M27-A3. 2008."},{"key":"305_CR26","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement-CLSI Document M27-S4-Wayne, PA. 2012."},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1128\/AAC.00349-06","volume":"50","author":"S Katiyar","year":"2006","unstructured":"Katiyar S, Pfaller M, Edlind T. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility. Antimicrob Agents Chemother. 2006;50:2892\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503\u201335.","journal-title":"Clin Infect Dis"},{"key":"305_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jac\/dkx008","volume":"72","author":"DA Boikov","year":"2017","unstructured":"Boikov DA, Locke JB, James KD, Bartizal K, Sobel JD. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. J Antimicrob Chemother. 2017;72:1355\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/mmy\/myy016","volume":"57","author":"S Sharifynia","year":"2019","unstructured":"Sharifynia S, Rezaie S, Mohamadnia A, Mortezaee V, Hadian A, Seyedmousavi S. Genetic diversity and antifungal susceptibility of Candida albicans isolated from Iranian patients. Med Mycol. 2019;57:127\u201331.","journal-title":"Med Mycol"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1128\/JCM.00872-06","volume":"44","author":"M Pfaller","year":"2006","unstructured":"Pfaller M, Boyken L, Hollis R, Messer S, Tendolkar S, Diekema D. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. J Clin Microbiol. 2006;44:3533\u20138.","journal-title":"J Clin Microbiol"},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/JCM.01901-07","volume":"46","author":"M Pfaller","year":"2008","unstructured":"Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, Tendolkar S, et al. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol. 2008;46:150\u20136.","journal-title":"J Clin Microbiol"},{"key":"305_CR33","first-page":"429","volume":"32","author":"XY Lin","year":"2003","unstructured":"Lin XY, Wang SL, Duan XL, Lan CG, Chen XJ, Xue J, et al. Review of clinical experience in itraconazole therapy for 10\u00a0years in China. J Clin Dermatol. 2003;32:429\u201330 (in Chinese).","journal-title":"J Clin Dermatol."},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1128\/JCM.02363-09","volume":"48","author":"GM Lyon","year":"2010","unstructured":"Lyon GM, Karatela S, Sunay S, Adiri Y. Antifungal susceptibility testing of Candida isolates from the Candida surveillance study. J Clin Microbiol. 2010;48:1270\u20135.","journal-title":"J Clin Microbiol"},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1128\/AAC.01217-06","volume":"51","author":"H Seifert","year":"2007","unstructured":"Seifert H, Aurbach U, Stefanik D, Cornely O. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother. 2007;51:1818\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"305_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11046-014-9772-2","volume":"178","author":"M Castanheira","year":"2014","unstructured":"Castanheira M, Messer SA, Rhomberg PR, Dietrich RR, Jones RN, Pfaller MA. Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values. Mycopathologia. 2014;178:1\u20139.","journal-title":"Mycopathologia"},{"key":"305_CR37","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1128\/JCM.40.5.1694-1697.2002","volume":"40","author":"M Pfaller","year":"2002","unstructured":"Pfaller M, Diekema D, Messer S, Boyken L, Huynh H, Hollis R. Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole. J Clin Microbiol. 2002;40:1694\u20137.","journal-title":"J Clin Microbiol"},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1128\/AAC.46.6.1723-1727.2002","volume":"46","author":"M Pfaller","year":"2002","unstructured":"Pfaller M, Messer S, Hollis R, Jones R, Diekema D. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother. 2002;46:1723\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1128\/JCM.02591-05","volume":"44","author":"CR Sims","year":"2006","unstructured":"Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol. 2006;44:2105\u20138.","journal-title":"J Clin Microbiol"},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","volume":"39","author":"M Pfaller","year":"2001","unstructured":"Pfaller M, Diekema D, Jones R, Sader HS, Fluit A, Hollis R, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol. 2001;39:3254\u20139.","journal-title":"J Clin Microbiol"},{"key":"305_CR41","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1128\/JCM.42.7.3137-3141.2004","volume":"42","author":"M Pfaller","year":"2004","unstructured":"Pfaller M, Messer S, Boyken L, Rice C, Tendolkar S, Hollis R, et al. Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp. J Clin Microbiol. 2004;42:3137\u201341.","journal-title":"J Clin Microbiol"},{"key":"305_CR42","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1128\/JCM.00863-13","volume":"51","author":"MA Pfaller","year":"2013","unstructured":"Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. In vitro activity of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and moulds. J Clin Microbiol. 2013;51:2608\u201316.","journal-title":"J Clin Microbiol"},{"key":"305_CR43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1128\/AAC.01512-07","volume":"52","author":"J Guinea","year":"2008","unstructured":"Guinea J, Pel\u00e1ez T, Recio S, Torres-Narbona M, Bouza E. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species. Antimicrob Agents Chemother. 2008;52:1396\u2013400.","journal-title":"Antimicrob Agents Chemother"},{"key":"305_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11046-011-9460-4","volume":"73","author":"C Marcos Arias","year":"2012","unstructured":"Marcos Arias C, Eraso E, Madariaga L, Carrillo Mu\u00f1oz AJ, Quind\u00f3s G. In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis. Mycopathologia. 2012;73:35\u201346.","journal-title":"Mycopathologia"},{"key":"305_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2003.09.008","volume":"48","author":"M Pfaller","year":"2004","unstructured":"Pfaller M, Messer S, Boyken L, Hollis R, Rice C, Tendolkar S, et al. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis. 2004;48:201\u20135.","journal-title":"Diagn Microbiol Infect Dis."},{"key":"305_CR46","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1128\/AAC.05025-11","volume":"56","author":"CS Danby","year":"2012","unstructured":"Danby CS, Boikov D, Rautemaa-Richardson R, Sobel JD. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob Agents Chemother. 2012;56:1403\u20136.","journal-title":"Antimicrob Agents Chemother."},{"key":"305_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mycmed.2014.10.021","volume":"25","author":"W Alfouzan","year":"2015","unstructured":"Alfouzan W, Dhar R, Ashkanani H, Gupta M, Rachel C, Khan Z. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait. J Mycol Med. 2015;25:23\u20138.","journal-title":"J Mycol Med."},{"key":"305_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jac\/dkf074","volume":"50","author":"M Laverdiere","year":"2002","unstructured":"Laverdiere M, Hoban D, Restieri C, Habel F. In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. J Antimicrob Chemother. 2002;50:119\u201323.","journal-title":"J Antimicrob Chemother."},{"key":"305_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010909504071","volume":"151","author":"M Ribeiro","year":"2001","unstructured":"Ribeiro M, Dietze R, Paula C, Da Matta D, Colombo A. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia. 2001;151:5\u201310.","journal-title":"Mycopathologia"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-018-0305-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:02:08Z","timestamp":1721142128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-018-0305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s11046-018-0305-2","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}